Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 7/2019

16.05.2019 | Retinal Disorders

Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography

verfasst von: Daniel Pauleikhoff, Frederic Gunnemann, Marius Book, Kai Rothaus

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the different appearances of vascular changes in macular telangiectasia type 2 (MacTel) and to describe their possible progression, the vascular patterns in different retinal layers were analyzed with optical coherence tomography angiography (OCT-A) and the findings were correlated with a spectral-domain OCT (SD-OCT) disease severity scale based on the extent of ellipsoid zone (EZ) loss.

Methods

Participants from the MacTel Study Group in Muenster and a healthy cohort were investigated with OCT-A using RTVue XR Avanti. After segmentation of the superficial capillary network, the deep capillary network, and the outer retina (OR), flow density was analyzed using Optovue software. Then, the images were exported using the software Fiji (National Institute of Mental Health, Bethesda, MD, USA) and analyzed with the automated MATLAB program (Mathworks, Version R2014b). Four parameters (total vessel length, number of vessel branches, number of vessel segments, and fractal dimension) were examined on the vascular skeletons (temporal, foveal, nasal, and total fields of the ETDRS grid). In addition, linear and area measurements of EZ loss were performed on SD-OCT volume scans. Progression characteristics and correlation between linear and area measurements were analyzed using linear mixed effects models.

Results

Twenty eyes of healthy probands (20 OCT-A and 20 SD-OCT scans) and 122 eyes of 61 MacTel patients were included. In order to classify the severity of the disease, MacTel eyes were assigned to a SD-OCT “disease severity scale” (grade 1 = no EZ loss; grade 2 = EZ loss temporal to the fovea; grade 3 = EZ loss including the fovea and the region nasal to the fovea). Flow density and total vessel length showed only limited differences between healthy eyes and different grades of MacTel, but particularly the numbers of branches and vessel segments, as well as the fractal dimension values, demonstrated significant and progressive reduction in the superficial and deep capillary networks of the temporal, nasal, and total ETDRS fields. Moreover, the outer retina showed a progressive presence of hyperreflective material in SD-OCT grades 2 and 3 eyes with associated vascular patterns in the OR on OCT-A.

Conclusions

In SD-OCT, the severity of MacTel is characterized by progressive EZ loss, which may be used as a simple clinical “disease severity scale”. In addition, OCT-A enables visualization and quantification of vascular patterns with mathematical methods. The morphological progression of the disease correlated significantly with progressive vascular changes, especially in respect of the numbers of branches and vessel segments as well as fractal dimension. This suggests that the severity of neurodegenerative and neurovascular changes develops in parallel and that the analysis and quantification of the vascular changes in the superficial and deep capillary networks may become an additional parameter for future treatment trials. Moreover, the significant association between hyperreflective material progressively visible on SD-OCT in the OR, which most often contains vessels in OCT-A, and advancing SD-OCT severity grades, as well as vascular changes in OCT-A, supports the concept of retinal neovascularization in the OR in patients with advanced MacTel.
Literatur
1.
Zurück zum Zitat Powner MB, Gillies MC, Tretiach M et al (2010) Perifoveal Müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology 117:2407–2416CrossRefPubMed Powner MB, Gillies MC, Tretiach M et al (2010) Perifoveal Müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology 117:2407–2416CrossRefPubMed
2.
Zurück zum Zitat Powner MB, Gillies MC, Zhu M et al (2013) Loss of Müller’s cells and photoreceptors in macular telangiectasia type 2. Ophthalmology 120:2344–2352CrossRefPubMed Powner MB, Gillies MC, Zhu M et al (2013) Loss of Müller’s cells and photoreceptors in macular telangiectasia type 2. Ophthalmology 120:2344–2352CrossRefPubMed
3.
Zurück zum Zitat Issa PC, Gillies MC, Chew EY et al (2013) Macular telangiectasia type 2. Prog Retin Eye Res 34:49–77CrossRef Issa PC, Gillies MC, Chew EY et al (2013) Macular telangiectasia type 2. Prog Retin Eye Res 34:49–77CrossRef
4.
Zurück zum Zitat Gass JDM (1968) A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease: V. retinal telangiectasis. Arch Ophthalmol 80:592–605CrossRefPubMed Gass JDM (1968) A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease: V. retinal telangiectasis. Arch Ophthalmol 80:592–605CrossRefPubMed
5.
Zurück zum Zitat Gass JD, Oyakawa RT (1982) Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 100:769–780CrossRefPubMed Gass JD, Oyakawa RT (1982) Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 100:769–780CrossRefPubMed
6.
Zurück zum Zitat Gass JDM, Blodi BA (1993) Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology 100:1536–1546CrossRefPubMed Gass JDM, Blodi BA (1993) Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology 100:1536–1546CrossRefPubMed
7.
Zurück zum Zitat Esposti SD, Egan C, Bunce C et al (2012) Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis. Invest Ophthalmol Vis Sci 53:6568–6575CrossRefPubMed Esposti SD, Egan C, Bunce C et al (2012) Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis. Invest Ophthalmol Vis Sci 53:6568–6575CrossRefPubMed
8.
Zurück zum Zitat Zeimer MB, Padge B, Heimes B, Pauleikhoff D (2010) Idiopathic macular telangiectasia type 2: distribution of macular pigment and functional investigations. Retina 30:586–595CrossRefPubMed Zeimer MB, Padge B, Heimes B, Pauleikhoff D (2010) Idiopathic macular telangiectasia type 2: distribution of macular pigment and functional investigations. Retina 30:586–595CrossRefPubMed
9.
Zurück zum Zitat Issa PC, Berendschot TTJM, Staurenghi G et al (2008) Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 49:1172–1177CrossRef Issa PC, Berendschot TTJM, Staurenghi G et al (2008) Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 49:1172–1177CrossRef
10.
Zurück zum Zitat Sallo FB, Leung I, Zeimer M et al (2018) Abnormal retinal reflectivity to short-wavelength light in type 2 idiopathic macular teleangiectasis. Retina 38:S79–S88CrossRefPubMedPubMedCentral Sallo FB, Leung I, Zeimer M et al (2018) Abnormal retinal reflectivity to short-wavelength light in type 2 idiopathic macular teleangiectasis. Retina 38:S79–S88CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Gaudric A, de Lahitte GD, Cohen SY et al (2006) Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 124:1410–1419CrossRefPubMed Gaudric A, de Lahitte GD, Cohen SY et al (2006) Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 124:1410–1419CrossRefPubMed
12.
Zurück zum Zitat Sallo FB, Leung I, Clemons TE et al (2015) Multimodal imaging in type 2 idiopathic macular teleangiectasis. Retina 35:742–749CrossRefPubMed Sallo FB, Leung I, Clemons TE et al (2015) Multimodal imaging in type 2 idiopathic macular teleangiectasis. Retina 35:742–749CrossRefPubMed
13.
Zurück zum Zitat Sallo FB, Peto T, Egan C et al (2012) “En face” OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 53:6145–6152CrossRefPubMedPubMedCentral Sallo FB, Peto T, Egan C et al (2012) “En face” OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 53:6145–6152CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Sallo FB, Peto T, Egan C et al (2012) The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 53:7889–7895CrossRefPubMedPubMedCentral Sallo FB, Peto T, Egan C et al (2012) The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 53:7889–7895CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Mukherjee D, Lad EM, Vann RR et al (2017) Correlation between macular integrity assessment and optical coherence tomography imaging of ellipsoid zone in macular telangiectasia type 2. Invest Ophthalmol Vis Sci 58:291–299CrossRef Mukherjee D, Lad EM, Vann RR et al (2017) Correlation between macular integrity assessment and optical coherence tomography imaging of ellipsoid zone in macular telangiectasia type 2. Invest Ophthalmol Vis Sci 58:291–299CrossRef
16.
Zurück zum Zitat Heeren TFC, Kitka D, Florea D et al (2018) Longitudinal correlation of ellipsoid zone loss and functional loss in macular telangiectasia type 2. Retina 38:S20–S26PubMedPubMedCentral Heeren TFC, Kitka D, Florea D et al (2018) Longitudinal correlation of ellipsoid zone loss and functional loss in macular telangiectasia type 2. Retina 38:S20–S26PubMedPubMedCentral
17.
Zurück zum Zitat Okada M, Robson AG, Egan CA et al (2018) Electrophysiological characterization of macular telangiectasia type 2 and structure-function correlation. Retina 38:S33–S42PubMed Okada M, Robson AG, Egan CA et al (2018) Electrophysiological characterization of macular telangiectasia type 2 and structure-function correlation. Retina 38:S33–S42PubMed
18.
Zurück zum Zitat Peto T, Heeren TFC, Clemons TE et al (2018) Correlation of clinical and functional progression with visual acuity loss in macular telangiectasia type 2: macTel project report no. 6–the macTel research group. Retina 38:S8–S13PubMedPubMedCentral Peto T, Heeren TFC, Clemons TE et al (2018) Correlation of clinical and functional progression with visual acuity loss in macular telangiectasia type 2: macTel project report no. 6–the macTel research group. Retina 38:S8–S13PubMedPubMedCentral
19.
Zurück zum Zitat Chew EY, Clemons TE, Jaffe GJ, et al (2019) Effect of ciliary neurotrophic factor on retinalneurodegeneration in patients with macular telangiectasia type 2: a randomized clinical trial. Ophthalmology 126(4):540–549 Chew EY, Clemons TE, Jaffe GJ, et al (2019) Effect of ciliary neurotrophic factor on retinalneurodegeneration in patients with macular telangiectasia type 2: a randomized clinical trial. Ophthalmology 126(4):540–549
20.
Zurück zum Zitat Jia Y, Tan O, Tokayer J et al (2012) Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 20:4710–4725CrossRefPubMedPubMedCentral Jia Y, Tan O, Tokayer J et al (2012) Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 20:4710–4725CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Zeimer M, Gutfleisch M, Heimes B et al (2015) Association between changes in macular vasculature in optical coherence tomography- and fluorescein-angiography and distribution of macular pigment in type 2 idiopathic macular teleangiectasia. Retina 35:2307–2316CrossRefPubMed Zeimer M, Gutfleisch M, Heimes B et al (2015) Association between changes in macular vasculature in optical coherence tomography- and fluorescein-angiography and distribution of macular pigment in type 2 idiopathic macular teleangiectasia. Retina 35:2307–2316CrossRefPubMed
22.
Zurück zum Zitat Gaudric A, Krivosic V, Tadayoni R (2015) Outer retina capillary invasion and ellipsoid zone loss in macular teleangiectasia type 2 imaged by OCT angiography. Retina 35:2300–2306CrossRefPubMed Gaudric A, Krivosic V, Tadayoni R (2015) Outer retina capillary invasion and ellipsoid zone loss in macular teleangiectasia type 2 imaged by OCT angiography. Retina 35:2300–2306CrossRefPubMed
23.
Zurück zum Zitat Spaide RF, Marco RD, Yannuzzi LA (2018) Vascular distortion and dragging related to apparent tissue contraction in macular teleangictasis type 2. Retina 38:S51–S60PubMed Spaide RF, Marco RD, Yannuzzi LA (2018) Vascular distortion and dragging related to apparent tissue contraction in macular teleangictasis type 2. Retina 38:S51–S60PubMed
24.
Zurück zum Zitat Spaide RF, Yannuzzi LA, Maloca PM (2018) Retinal-choroidal anastomosis in macular teleangictasis type 2. Retina 38:1920–1929CrossRefPubMed Spaide RF, Yannuzzi LA, Maloca PM (2018) Retinal-choroidal anastomosis in macular teleangictasis type 2. Retina 38:1920–1929CrossRefPubMed
25.
Zurück zum Zitat Faatz H, Rothaus K, Gunnemann F et al (2017) Changes in OCT angiography of type 2 CNV in neovascular AMD during anti-VEGF treatment. Klin Monatsbl Augenheilkd 234:1125–1131CrossRefPubMed Faatz H, Rothaus K, Gunnemann F et al (2017) Changes in OCT angiography of type 2 CNV in neovascular AMD during anti-VEGF treatment. Klin Monatsbl Augenheilkd 234:1125–1131CrossRefPubMed
26.
Zurück zum Zitat Pauleikhoff D, Bonelli R, Dubis A et al (2019) Progression characteristics of ellipsoid zone loss in macular teleangiectasia type 2. Ophthalmologica: Epub ahead of print Pauleikhoff D, Bonelli R, Dubis A et al (2019) Progression characteristics of ellipsoid zone loss in macular teleangiectasia type 2. Ophthalmologica: Epub ahead of print
27.
Zurück zum Zitat Faatz H, Farecki ML, Rothaus K et al (2019) Optical coherence tomography angiography of type 1 and 2 neovascularisations in age-related macular degeneration under anti-VEGF therapy: evaluation of a new quantitative method. Eye: Epub ahead of print Faatz H, Farecki ML, Rothaus K et al (2019) Optical coherence tomography angiography of type 1 and 2 neovascularisations in age-related macular degeneration under anti-VEGF therapy: evaluation of a new quantitative method. Eye: Epub ahead of print
28.
Zurück zum Zitat Rothaus K, Jiang X (2005) Multi-scale midline extraction using creaseness. Pattern recognition and image analysis. Springer, Berlin, pp 502–511CrossRef Rothaus K, Jiang X (2005) Multi-scale midline extraction using creaseness. Pattern recognition and image analysis. Springer, Berlin, pp 502–511CrossRef
29.
Zurück zum Zitat López AM, Lloret D, Serrat J, Villanueva JJ (2000) Multilocal creaseness based on the level-set extrinsic curvature. Comput Vis Image Underst 77:111–144CrossRef López AM, Lloret D, Serrat J, Villanueva JJ (2000) Multilocal creaseness based on the level-set extrinsic curvature. Comput Vis Image Underst 77:111–144CrossRef
30.
Zurück zum Zitat Leung I, Sallo FB, Bonelli R et al (2018) Characteristics of pigmented lesions in type 2 idiopathic macular teleangiectasia. Retina 38:43–50CrossRef Leung I, Sallo FB, Bonelli R et al (2018) Characteristics of pigmented lesions in type 2 idiopathic macular teleangiectasia. Retina 38:43–50CrossRef
31.
Zurück zum Zitat Milam AH, Li ZY, Fariss RN (1998) Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res 17:175–205CrossRefPubMed Milam AH, Li ZY, Fariss RN (1998) Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res 17:175–205CrossRefPubMed
32.
Zurück zum Zitat Kupitz EH, Heeren TFC, Holz FG, Charbel Issa P (2015) Poor long-term outcome of anti-VEGF therapy in nonproliferative macular teleangiectasia type 2. Retina 35:2619–2626CrossRefPubMed Kupitz EH, Heeren TFC, Holz FG, Charbel Issa P (2015) Poor long-term outcome of anti-VEGF therapy in nonproliferative macular teleangiectasia type 2. Retina 35:2619–2626CrossRefPubMed
33.
Zurück zum Zitat Spaide RF, Klancnik JM, Cooney MJ (2015) Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. JAMA Ophthalmol 133:66–73CrossRefPubMed Spaide RF, Klancnik JM, Cooney MJ (2015) Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. JAMA Ophthalmol 133:66–73CrossRefPubMed
Metadaten
Titel
Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography
verfasst von
Daniel Pauleikhoff
Frederic Gunnemann
Marius Book
Kai Rothaus
Publikationsdatum
16.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 7/2019
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-019-04323-0

Weitere Artikel der Ausgabe 7/2019

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2019 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.